tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

SLXN Stock Latest News

Silexion Therapeutics Holds Annual General Meeting
Company AnnouncementsSilexion Therapeutics Holds Annual General Meeting
2h ago
8K
SLXN
Silexion Announces Positive Preclinical Results for SIL204
PremiumCompany Announcements
Silexion Announces Positive Preclinical Results for SIL204
5d ago
8K
SLXN
Silexion Therapeutics announces results from preclinical study of SIL204
PremiumThe Fly
Silexion Therapeutics announces results from preclinical study of SIL204
5d ago
SLXN
Silexion Therapeutics Stays Listed on Nasdaq After Appeal
PremiumCompany Announcements
Silexion Therapeutics Stays Listed on Nasdaq After Appeal
6d ago
8K
SLXN
Silexion Therapeutics Requests Hearing on Nasdaq Delisting
PremiumCompany Announcements
Silexion Therapeutics Requests Hearing on Nasdaq Delisting
1M ago
8K
SLXN
Promising Future for Silexion Therapeutics: Buy Rating Reiterated Due to SIL-204’s Potential in KRAS-Mutated Cancers
PremiumRatingsPromising Future for Silexion Therapeutics: Buy Rating Reiterated Due to SIL-204’s Potential in KRAS-Mutated Cancers
1M ago
SLXN
Silexion Therapeutics Unveils Promising Preclinical Results for SIL204
Premium
Company Announcements
Silexion Therapeutics Unveils Promising Preclinical Results for SIL204
2M ago
8K
SLXN
Silexion Therapeutics announces preclinical results on SIL204
Premium
The Fly
Silexion Therapeutics announces preclinical results on SIL204
2M ago
SLXN
Silexion Therapeutics Receives Nasdaq Delisting Notice
PremiumCompany Announcements
Silexion Therapeutics Receives Nasdaq Delisting Notice
2M ago
8K
SLXN
Silexion Completes Key Preclinical Studies for SIL204
PremiumCompany Announcements
Silexion Completes Key Preclinical Studies for SIL204
2M ago
8K
SLXN
Silexion Therapeutics completes preclinical studies on SIL204
PremiumThe Fly
Silexion Therapeutics completes preclinical studies on SIL204
2M ago
SLXN
Silexion Therapeutics’ Promising Future: Buy Rating Backed by Expanding Market Potential and Strong Financial Position
PremiumRatings
Silexion Therapeutics’ Promising Future: Buy Rating Backed by Expanding Market Potential and Strong Financial Position
2M ago
SLXN
Silexion Therapeutics Partners with Catalent for SIL204 Development
PremiumCompany AnnouncementsSilexion Therapeutics Partners with Catalent for SIL204 Development
3M ago
8K
SLXN
Silexion Therapeutics enters collaboration with Catalent
Premium
The Fly
Silexion Therapeutics enters collaboration with Catalent
3M ago
SLXN
Buy Rating for Silexion Therapeutics Driven by Promising SIL-204 Developments and Market Expansion
Premium
Ratings
Buy Rating for Silexion Therapeutics Driven by Promising SIL-204 Developments and Market Expansion
4M ago
SLXN
Silexion Therapeutics Expands SIL204 Development Plan
PremiumCompany Announcements
Silexion Therapeutics Expands SIL204 Development Plan
4M ago
8K
SLXN
Silexion Therapeutics announces expanded development plan for SIL204
PremiumThe Fly
Silexion Therapeutics announces expanded development plan for SIL204
4M ago
SLXN
Silexion announces completion of expanded development plan for SIL204
PremiumThe Fly
Silexion announces completion of expanded development plan for SIL204
4M ago
SLXN
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
4M ago
PLX
SLS
Silexion Therapeutics price target lowered to $5 from $9 at Maxim
PremiumThe FlySilexion Therapeutics price target lowered to $5 from $9 at Maxim
4M ago
SLXN
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
4M ago
PLX
ANNX
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
4M ago
ACIU
ADMA

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >